TXG
10x Genomics, Inc. Class A Common Stock
LABORATORY ANALYTICAL INSTRUMENTS
Best Lab Instruments Stocks 2026 →
10x Genomics (TXG) Stock: Buy, Sell, or Hold?
$62.90
-2.15 (-3.31%)
▼
5d:
-3.66%
30d:
-16.35%
90d:
+8.92%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (65%)
Quality Score
56/100
Position
OVERSOLD
30-Day Fair Range
$64.36 – $82.24
Position: OVERSOLD
Forward P/E & Valuation
725.5x
STRETCHED
vs 185.8x historical avg
Wall Street Target
$68.50
+8.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$55.50 / $87.82
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: TXG trades at premium valuation expecting 57.5% growth. Hold existing positions but don't chase. Wait for better entry.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 30, 2026 at $70.11 · last confirmed Nov 10, 2026
Strength: 7.6/10
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $62.90, which is considered oversold relative to its 30-day fair value range of $64.36 to $82.24. From a valuation perspective, the stock is trading at a premium (Forward PE: 725.5) compared to its historical average (185.8). At these levels, the market is pricing in 57.5% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $55.50, while resistance sits at $87.82. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $55.50, while resistance sits at $87.82. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$64.36 -
$82.24
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.2%
Trading Range & Key Levels
30-Day Trading Range
$64.36 -
$82.24
Current vs Trading Range
OVERSOLD
Support Level
$55.50
Resistance Level
$87.82
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding TXG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- NEUTRAL: Near Wall St target ($68.50)
- BEARISH: Market expects 57.5% growth - appears too optimistic based on history
- NEUTRAL: Bottoming setup forming (55/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
725.49
Wall Street Target
$68.50
(+8.9%)
Revenue Growth (YoY)
1.1%
Profit Margin
-10.8%
Valuation Premium vs History
+57.5% premium
PE vs Historical
725.5 vs 185.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+57.5%
(market-implied from PE analysis)
1-Year Target
$94.35
(+50%)
2-Year Target
$141.53
(+125%)
3-Year Target
$212.29
(+238%)
3-Yr Target (if PE normalizes)
(PE: 725→186)
PE COMPRESSION
$54.37
(-14%)
Significant PE compression expected
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 725.5, Growth: 37.0%)
$161.62
(+157%)
Base:
(SPY PE: 19.9, Growth: 37.0%)
$4.42
(-93%)
Bear:
(PE: 16.9, Growth: 37.0%)
$3.76
(-94%)
Share TXG Analysis
Share this live TXG analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TXG)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 14, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message expresses gratitude towards $TXG for significant gains.
Key Retail Themes:
appreciation for gains
positive sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:36 PM ET
Data refreshes hourly during market hours. Next update: 10:36 PM
Data refreshes hourly during market hours. Next update: 10:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Advanced TXG Option Strategies
Professional options setups generated by AI based on today's TXG price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TXG Research Pages
